Unusual 11 Mid-Day Movers 5/11: DECC, CNB, TSFG, CTIC Higher; FACE, CPSL, SWSI, AXL Lower

May 11, 2009 12:37 PM EDT

D&E Communications, Inc. (Nasdaq: DECC) 52.3% HIGHER; entered into a definitive merger agreement to be acquired by Windstream Corporation (NYSE: WIN) in a transaction valued at approximately $330 million. Click here for the full report.

Colonial Bancgroup Inc. (NYSE: CNB) 51.9% HIGHER; shares of Colonial surged more than 40% last week despite no news. The stock is continuing higher today on continued heavy volume. Notably, the stock has risen about 106% in the last 2 trading days.

Physicians Formula Holdings, Inc. (Nasdaq: FACE) 49.2% LOWER; reports Q1 loss of $0.13, versus the analyst estimate of $0.04. Revenue for the quarter was $20.2 million, versus the consensus of $30.29 million.

The South Financial Group (Nasdaq: TSFG) 34.3% HIGHER; spiking today following the filing of its Form 10-Q late Friday night.

Cell Therapeutics (Nasdaq: CTIC) 29.6% HIGHER; continuing higher this week following a 150% run-up last week amid Pixantrone news and general strength in the bustling biotech sector.

BioFuel Energy (Nasdaq: BIOF) 28.9% HIGHER; continuing higher today following a 280% surge last week on no news.

Cytori Therapeutics (NYSE: CYTX) 26.4% HIGHER; reports Q1 EPS of ($0.20), 2 cents below the analyst estimate of ($0.18). Revenue for the quarter was $1.91 million, versus the consensus of $1.9 million.

China Precision Steel (Nasdaq: CPSL) 22.1% LOWER; reports Q3 EPS of ($0.08), 10 cents below the analyst estimate of $0.02. Revenue for the quarter was $7.62 million, versus the consensus of $12.12 million.

Superior Well Services, Inc. (Nasdaq: SWSI) 21.1% LOWER; reports Q1 loss of $0.67, versus the analyst estimate of ($0.08). Revenue for the quarter was $122.3 million, versus the consensus of $148.10 million.

American Axle (NYSE: AXL) 20% LOWER; correcting today following a 165% run-up on Friday on the bank of a Deutsche Bank upgrade. The positive note pushed the entire auto supplier sector sharply higher Friday.

Hemispherx Biopharma (AMEX: HEB) 15.9% LOWER; announced today that it has agreed to sell up to $18.3 million in common stock and warrants in a registered offering to two institutional investors. The investors will purchase today, for $15 million cash, common shares of its stock at $1.10 per share.

To get this report daily visit http://www.streetinsider.com/entities/Unusual+11+Mid-Day+Movers.


Related Categories

Special Reports

Stocks Mentioned

AXL 7.00

+0.11 +1.60%
Volume: 3,336,217
Track AXL

BIOF 1.34

+0.07 +5.51%
Volume: 88,568
Track BIOF

CNB 0.41

+0.00 +0.00%
Volume: 444,909
Track CNB

CPSL 2.38

+0.10 +4.39%
Volume: 487,132
Track CPSL

CTIC 0.99

-0.03 -2.94%
Volume: 4,777,067
Track CTIC

CYTX 3.55

+0.05 +1.43%
Volume: 264,233
Track CYTX

DECC 11.63

-0.02 -0.17%
Volume: 57,193
Track DECC

FACE 2.35

+0.04 +1.73%
Volume: 116,730
Track FACE

HEB 1.22

-0.03 -2.40%
Volume: 1,426,577
Track HEB

SWSI 10.80

-0.21 -1.91%
Volume: 327,004
Track SWSI

TSFG 0.75

+0.06 +8.70%
Volume: 3,083,545
Track TSFG

WIN 10.28

+0.10 +0.98%
Volume: 4,161,997
Track WIN


Related Entities


Add Your Comment